These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16029037

  • 1. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
    Nelson MH, Stein DA, Kroeker AD, Hatlevig SA, Iversen PL, Moulton HM.
    Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
    [Abstract] [Full Text] [Related]

  • 2. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
    Moulton HM, Nelson MH, Hatlevig SA, Reddy MT, Iversen PL.
    Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
    [Abstract] [Full Text] [Related]

  • 3. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
    Deere J, Iversen P, Geller BL.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
    [Abstract] [Full Text] [Related]

  • 4. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM.
    Bioconjug Chem; 2007 Jan; 18(1):50-60. PubMed ID: 17226957
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.
    Amantana A, Moulton HM, Cate ML, Reddy MT, Whitehead T, Hassinger JN, Youngblood DS, Iversen PL.
    Bioconjug Chem; 2007 Jan; 18(4):1325-31. PubMed ID: 17583927
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
    Geller BL, Deere J, Tilley L, Iversen PL.
    J Antimicrob Chemother; 2005 Jun; 55(6):983-8. PubMed ID: 15872045
    [Abstract] [Full Text] [Related]

  • 8. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
    Tilley LD, Hine OS, Kellogg JA, Hassinger JN, Weller DD, Iversen PL, Geller BL.
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
    [Abstract] [Full Text] [Related]

  • 9. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
    Moulton HM, Fletcher S, Neuman BW, McClorey G, Stein DA, Abes S, Wilton SD, Buchmeier MJ, Lebleu B, Iversen PL.
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):826-8. PubMed ID: 17635157
    [Abstract] [Full Text] [Related]

  • 10. Five-step process for screening antisense compounds for efficacy: gene target IL-12Rb2.
    Marshall NB, Hauck LL, Mourich DV.
    Methods Mol Biol; 2011 Aug; 764():153-68. PubMed ID: 21748639
    [Abstract] [Full Text] [Related]

  • 11. Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.
    Marshall NB, Oda SK, London CA, Moulton HM, Iversen PL, Kerkvliet NI, Mourich DV.
    J Immunol Methods; 2007 Aug 31; 325(1-2):114-26. PubMed ID: 17673254
    [Abstract] [Full Text] [Related]

  • 12. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S, Moulton HM, Clair P, Prevot P, Youngblood DS, Wu RP, Iversen PL, Lebleu B.
    J Control Release; 2006 Dec 01; 116(3):304-13. PubMed ID: 17097177
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers.
    Amantana A, Iversen PL.
    Curr Opin Pharmacol; 2005 Oct 01; 5(5):550-5. PubMed ID: 16087398
    [Abstract] [Full Text] [Related]

  • 14. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
    Enterlein S, Warfield KL, Swenson DL, Stein DA, Smith JL, Gamble CS, Kroeker AD, Iversen PL, Bavari S, Mühlberger E.
    Antimicrob Agents Chemother; 2006 Mar 01; 50(3):984-93. PubMed ID: 16495261
    [Abstract] [Full Text] [Related]

  • 15. Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models.
    Burrer R, Neuman BW, Ting JP, Stein DA, Moulton HM, Iversen PL, Kuhn P, Buchmeier MJ.
    J Virol; 2007 Jun 01; 81(11):5637-48. PubMed ID: 17344287
    [Abstract] [Full Text] [Related]

  • 16. Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.
    Swenson DL, Warfield KL, Warren TK, Lovejoy C, Hassinger JN, Ruthel G, Blouch RE, Moulton HM, Weller DD, Iversen PL, Bavari S.
    Antimicrob Agents Chemother; 2009 May 01; 53(5):2089-99. PubMed ID: 19223614
    [Abstract] [Full Text] [Related]

  • 17. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.
    Moulton HM, Hase MC, Smith KM, Iversen PL.
    Antisense Nucleic Acid Drug Dev; 2003 Feb 01; 13(1):31-43. PubMed ID: 12691534
    [Abstract] [Full Text] [Related]

  • 18. Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers.
    Ghosh C, Iversen PL.
    Antisense Nucleic Acid Drug Dev; 2000 Aug 01; 10(4):263-74. PubMed ID: 10984120
    [Abstract] [Full Text] [Related]

  • 19. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
    Pannier AK, Arora V, Iversen PL, Brand RM.
    Int J Pharm; 2004 May 04; 275(1-2):217-26. PubMed ID: 15081152
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.